Funding
Cancer
CANCER
Open access funding provided by University of Bergen (incl Haukeland University Hospital). This work received funding from Helse Vest (grant numbers 912062, 911626, 911747, 911582, 911778, 912226, and 980058), the Helse Vest Strategic grants of Personalized Therapy (grant number 303484) and the Bergen Stem Cell Consortium (grant number 502027). This work was partly supported by the Research Council of Norway through its Centres of Excellence funding scheme (project number 223250), the Research Council of Norway NFR BEHANDLING programme (project number 287829), the Norwegian Cancer Society (project number 197984), and the Bergen Research Foundation/Trond Mohn Stiftelse.